Search global stocks & ETFs...Ctrl K
Learn Mode
Quest Diagnostics IncDGX
$200.29
$4.17 (2.126%)
$200.91
$0.62 (0.311%)
DGX
Stock Profile
07-20
Recommended Metric
Score Card
Explore Scores Tab
3.55
Good
Valuation Model
Key Score
5.00
Very Good
Management
1.00
Very Bad
Growth
4.00
Good
Profitability
5.00
Very Good
Fin. Health
1.00
Very Bad
Dividends
5.00
Very Good
Analyst
5.00
Very Good
Insider Transactions
Explore Insider Tab ›Buy Transactions
Sell Transactions
Peers
Select stocks to compare
Price Targets & Ratings
View Analysis
1-year price targets, ending May 11, 2027
Current
$200.29
Baseline
High
$257.25
▲
28.44%
Avg
$226.14
▲
12.90%
Low
$181.02
▼
-9.62%
Analyst Ratings based on 24 Analysts
Strong Buy
625%
Buy
729%
Hold
1146%
Sell
000%
Strong Sell
000%
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. The company is headquartered in Secaucus, New Jersey and currently employs 46,000 full-time employees. The firm provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. The company operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. The company offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. The company also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.Read More
Stock News
View All Updates
News50%Bullish
Social52%Negative
Top S&P500 movers in Friday's pre-market session
1dChartMill
How The Quest Diagnostics (DGX) Investment Story Is Evolving Without New Analyst Price Target Changes
2dYahoo
DaVita HealthCare (DVA) Up 0.6% Since Last Earnings Report: Can It Continue?
2dYahoo
Encompass Health to Expand WV Footprint With 36-Bed Bridgeport Unit
5dYahoo
Quest Diagnostics (DGX) Upgraded to Buy: Here's What You Should Know
1wYahoo
3 Reasons to Sell DGX and 1 Stock to Buy Instead
1wYahoo
Are Medical Stocks Lagging Quest Diagnostics (DGX) This Year?
1wYahoo
Quest Diagnostics Stock: Analyst Estimates & Ratings
1wYahoo
1 Profitable Stock to Own for Decades and 2 We Avoid
2wYahoo
Why Is Quest Diagnostics (DGX) Down 5% Since Last Earnings Report?
2wYahoo
Reasons to Add Align Technology Stock to Your Portfolio Now
2wYahoo
Quest Diagnostics Declares Quarterly Cash Dividend
2wYahoo
Is This the Right Time to Hold DGX Stock in Your Portfolio?
2wYahoo
14. OURA
2wCNBC
Quest Diagnostics (NYSE:DGX): A Solid Dividend Play Backed by Strong Profitability and Financial Health
2wChartMill
How The Investment Narrative For Quest Diagnostics (DGX) Is Shifting With New Valuation Work
3wYahoo
Altria and 13 More Losing Stocks That Should Make a Comeback
3wYahoo
Quest Diagnostics, Altria, and 12 More Stocks That Are Coming Back to Life After a Rough Patch
3wYahoo
Oracle adds Cleveland Clinic CEO to board of directors
3wYahoo
Labcorp expands Epic pact to make full test menu available on Aura
3wYahoo
Tempus AI: My Pick For An Oncoming Boom In Demand For Data-Driven Precision Medicine
4wSeekingAlpha
Drug Screening Market Research and Global Forecast Report 2026-2036: Increasing Demand in Various Sectors Such As Workplaces, Criminal Justice Systems, and Drug Treatment Centers
4wYahoo
Bullish Quarterly Results: 3 Companies Raising Guidance
4wYahoo
Quest Diagnostics: Updating Levels After Q1 Earnings
4wSeekingAlpha
2 Things Matter Most in Picking Winning Stocks, Says This Market Pro
5wYahoo
Quest Diagnostics Debt Raise And ctDNA Alliance Spark Valuation Questions
5wYahoo
5 Must-Read Analyst Questions From Quest’s Q1 Earnings Call
5wYahoo
Quest Diagnostics Prices $500 Million of Senior Notes
5wYahoo
Orkes Raises $60M as Developers Increasingly Use Its Platform to Deploy AI Confidently in Production
6wYahoo
Quest Diagnostics: Good Q1, Solid Business, Steady Share Price Upside Likely
6wSeekingAlpha
These Companies Are Raising Guidance This Earnings Season
6wYahoo
UBS Maintains Neutral on Quest Diagnostics, Raises Price Target to $220
6wBenzinga
DGX Q1 Deep Dive: Organic Growth, Consumer Testing Momentum, and Advanced Diagnostics Drive Outlook
6wYahoo
These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Earnings
6wBenzinga
Baird Maintains Neutral on Quest Diagnostics, Raises Price Target to $229
6wBenzinga
Barclays Maintains Overweight on Quest Diagnostics, Raises Price Target to $230
6wBenzinga
Truist Securities Maintains Hold on Quest Diagnostics, Raises Price Target to $225
6wBenzinga
Quest Diagnostics Inc (DGX) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Raised ...
6wYahoo
How The Investment Story For Quest Diagnostics (DGX) Is Quietly Shifting Now
6wYahoo
Sector Update: Health Care Stocks Softer Late Afternoon
6wYahoo
Explore the top gainers and losers within the S&P500 index in today's session.
6wChartMill
Quest (DGX) Q1 2026 Earnings Transcript
6wYahoo
Quest Diagnostics Incorporated Q1 2026 Earnings Call Summary
6wYahoo
Top S&P500 movers in Tuesday's session
6wChartMill
Quest (DGX) Q4 2024 Earnings Transcript
6wYahoo
Quest (DGX) Q1 2025 Earnings Transcript
6wYahoo
Quest Diagnostics Q1 Earnings Call Highlights
6wYahoo
Which S&P500 stocks are gapping on Tuesday?
6wChartMill
The Most Impressive Part Of Quest Diagnostics Stock-Spiking First-Quarter Report
6wYahoo
Quest Diagnostics Gains Steam With Partnerships, Lifts Outlook
6wBenzinga
